Sumitomo ChemicalSUMITOMO CHEMICAL COMPANY, LIMITED4005東証プライム化学FY ending Mar 2026, consolidated, IFRS

Sumitomo Chemical FY ending Mar 2024 results

About 18% of Sumitomo Chemical's sales come from Essential and Green Materials, with Essential Chemicals and Plastics and ICT and Mobility Solutions making up much of the rest.

It lost about ¥20 for every ¥100 of sales at the operating level.

Revenue changed -15.5% from the prior year.

What changed from last year

FY ending Mar 2023 → FY ending Mar 2024

Revenue
-15.5%¥2.9T → ¥2.45T
Gross profit
-39.1%¥820.9B → ¥499.7B
Operating income
Loss-¥31B → -¥488.8B
Net income attributable to owners
-4563.1%¥6.99B → -¥311.8B
Operating cash flow
-146.0%¥111.6B → -¥51.3B

Where the money goes

FY ending Mar 2023 → FY ending Mar 2024

※ Segment revenues include inter-segment sales and are scaled to consolidated revenue

Where ¥100 of sales goes

For every ¥100 Sumitomo Chemical sells, how much goes where, and how much is kept.

FY ending Mar 2024
Cost of sales
¥80
SG&A
¥36
Other costs
¥4
Operating loss
¥20
Net loss
¥13

Annual margin trends

Gross margin20.4%
FY ending Mar 2020: 31.8%31.8%FY ending Mar 2021: 33.7%33.7%FY ending Mar 2022: 31.6%31.6%FY ending Mar 2023: 28.4%28.4%FY ending Mar 2024: 20.4%20.4%FY19FY20FY21FY22FY23FY24
Operating margin-20.0%
FY ending Mar 2020: 6.2%6.2%FY ending Mar 2021: 6.0%6.0%FY ending Mar 2022: 7.8%7.8%FY ending Mar 2023: -1.1%-1.1%FY ending Mar 2024: -20.0%-20.0%FY19FY20FY21FY22FY23FY24
Net margin-12.7%
FY ending Mar 2019: 5.1%5.1%FY ending Mar 2020: 1.4%1.4%FY ending Mar 2021: 2.0%2.0%FY ending Mar 2022: 5.9%5.9%FY ending Mar 2023: 0.2%0.2%FY ending Mar 2024: -12.7%-12.7%FY19FY20FY21FY22FY23FY24

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2024
  • Essential and Green Materials¥885.9B
    18%
    Op. margin -10.1%Industry: Chemicals
  • Essential Chemicals and Plastics¥774B
    16%
    Op. margin -11.7%
  • ICT and Mobility Solutions¥587.4B
    12%
    Op. margin 8.5%Industry: Chemicals
  • Health and agriculture related¥546B
    11%
    Op. margin 5.7%
  • Agro and Life Solutions¥515.6B
    11%
  • Information electronic chemistry¥414.1B
    9%
    Op. margin 10.6%
  • Medical products¥342.7B
    7%
    Op. margin -38.8%
  • Sumitomo Pharma¥313.8B
    7%
    Op. margin -40.3%Industry: Pharmaceuticals
  • Energy and functional materials¥300.3B
    6%
    Op. margin 2.6%
  • Other¥85.8B
    2%
    Op. margin 13.5%
  • Advanced Medical Solutions¥58.5B
    1%

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第145期(2025/04/01-2026/03/31)

    ID S100YAUO2026-06-22Open
  • EDINET (FSA Japan)

    有価証券報告書-第144期(2024/04/01-2025/03/31)

    ID S100VXZW2025-06-20Open
  • EDINET (FSA Japan)

    有価証券報告書-第143期(2023/04/01-2024/03/31)

    ID S100TMMW2024-06-21Open
  • EDINET (FSA Japan)

    有価証券報告書-第142期(2022/04/01-2023/03/31)

    ID S100QXTB2023-06-21Open
  • EDINET (FSA Japan)

    有価証券報告書-第141期(令和3年4月1日-令和4年3月31日)

    ID S100O9HK2022-06-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第140期(令和2年4月1日-令和3年3月31日)

    ID S100LJNG2021-06-23Open

Extracted from XBRL: 42

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.